Komiyama S, Watanabe H, Yanagita T, Kuwano M, Hiroto I
Auris Nasus Larynx. 1984;11(1):43-9. doi: 10.1016/s0385-8146(84)80017-6.
FAR therapy is effective for cancers of the head and neck, in particular laryngeal cancer. This combined chemoradiotherapy consists of 5-FU, vitamin A and radiation. We found 10% stomal recurrences in reviewing 112 patients who had been treated with total laryngectomy. Stomal recurrences after total laryngectomy occur frequently in patients undergoing an emergency tracheotomy. We studied 33 such patients divided into 2 groups, on the basis of whether laryngectomy had been carried out after the emergency tracheotomy plus preoperative FAR therapy, or whether laryngectomy had been carried out without preoperative FAR therapy. The incidence of stomal recurrence was less among those given preoperative FAR therapy and was statistically significant. Such being the case, preoperative FAR therapy seems to e prophylactically effective against stomal recurrence after emergency tracheotomy.
FAR疗法对头颈部癌症,尤其是喉癌有效。这种联合放化疗由5-氟尿嘧啶、维生素A和放疗组成。在回顾112例行全喉切除术的患者时,我们发现有10%的造口复发。全喉切除术后的造口复发在接受紧急气管切开术的患者中很常见。我们研究了33例这样的患者,根据紧急气管切开术加术前FAR疗法后是否进行了喉切除术,或者是否在没有术前FAR疗法的情况下进行了喉切除术,将其分为两组。术前接受FAR疗法的患者造口复发率较低,且具有统计学意义。既然如此,术前FAR疗法似乎对紧急气管切开术后的造口复发有预防作用。